| Literature DB >> 27423863 |
A Bedalov1, S Chowdhury1, J A Simon2.
Abstract
Sirtuins are a family of protein deacylases related by amino acid sequence and cellular function to the yeast Saccharomyces cerevisiae protein Sir2 (Silent Information Regulator-2), the first of this class of enzymes to be identified and studied in detail. Based on its initially discovered activity, Sir2 was classified as a histone deacetylase that removes acetyl groups from histones H3 and H4. The acetylation/deacetylation of these particular substrates leads to changes in transcriptional silencing at specific loci in the yeast genome, hence its name. Sirtuins, however, have been shown to regulate a wide variety of cellular processes beyond transcriptional repression in varied subcellular compartments and in different cell types. Mechanistically distinct from Zn(2+)-dependent deacylases, sirtuins use nicotinamide adenine dinucleotide as a cofactor in the removal of acetyl and other acyl groups linking metabolic status and posttranslational modification. Sirtuins' unique position has made them attractive targets for small-molecule drug development. In this chapter, we describe the biological roles, therapeutic areas in which sirtuins may play a role and development of small-molecule inhibitors of sirtuins employing phenotypic screening technologies ranging from assays in yeast, as well as biochemical screens to yield lead drug development candidates targeting a broad spectrum of human diseases.Entities:
Keywords: Acetylation; Aging; Cancer; Deacetylase; Epigenetic; Inhibitor; Metabolism; Mitochondria; Sirtuin; Transcription
Mesh:
Substances:
Year: 2016 PMID: 27423863 DOI: 10.1016/bs.mie.2016.03.011
Source DB: PubMed Journal: Methods Enzymol ISSN: 0076-6879 Impact factor: 1.600